aspirin has been researched along with Sickle Cell Trait in 4 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
Sickle Cell Trait: The condition of being heterozygous for hemoglobin S.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In this study, we describe, to the best of our knowledge, the first report of LV only associated with sickle cell trait with significant improvement on aspirin." | 7.78 | Livedoid vasculopathy associated with sickle cell trait: significant improvement on aspirin treatment. ( Abbas, O; El Khoury, J; Kibbi, AG; Kurban, M; Taher, A, 2012) |
| "The effects of low doses of aspirin on the frequency and severity of painful vaso-occlusive crises were evaluated in children with sickle hemoglobinopathies." | 5.05 | Trial of low doses of aspirin as prophylaxis in sickle cell disease. ( Greenberg, J; Halus, J; Ohene-Frempong, K; Schwartz, E; Way, C, 1983) |
| " In this study, we describe, to the best of our knowledge, the first report of LV only associated with sickle cell trait with significant improvement on aspirin." | 3.78 | Livedoid vasculopathy associated with sickle cell trait: significant improvement on aspirin treatment. ( Abbas, O; El Khoury, J; Kibbi, AG; Kurban, M; Taher, A, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lang, PA | 1 |
| Kasinathan, RS | 1 |
| Brand, VB | 1 |
| Duranton, C | 1 |
| Lang, C | 1 |
| Koka, S | 1 |
| Shumilina, E | 1 |
| Kempe, DS | 1 |
| Tanneur, V | 1 |
| Akel, A | 1 |
| Lang, KS | 1 |
| Foller, M | 1 |
| Kun, JF | 1 |
| Kremsner, PG | 1 |
| Wesselborg, S | 1 |
| Laufer, S | 1 |
| Clemen, CS | 1 |
| Herr, C | 1 |
| Noegel, AA | 1 |
| Wieder, T | 1 |
| Gulbins, E | 1 |
| Lang, F | 1 |
| Huber, SM | 1 |
| El Khoury, J | 1 |
| Taher, A | 1 |
| Kurban, M | 1 |
| Kibbi, AG | 1 |
| Abbas, O | 1 |
| Greenberg, J | 1 |
| Ohene-Frempong, K | 1 |
| Halus, J | 1 |
| Way, C | 1 |
| Schwartz, E | 1 |
| Worley, RJ | 1 |
| Gant, NF | 1 |
| Everett, RB | 1 |
| MacDonald, PC | 1 |
1 trial available for aspirin and Sickle Cell Trait
| Article | Year |
|---|---|
Trial of low doses of aspirin as prophylaxis in sickle cell disease.
Topics: Adolescent; Anemia, Sickle Cell; Aspirin; Blood Platelets; Child; Child, Preschool; Double-Blind Met | 1983 |
3 other studies available for aspirin and Sickle Cell Trait
| Article | Year |
|---|---|
Accelerated clearance of Plasmodium-infected erythrocytes in sickle cell trait and annexin-A7 deficiency.
Topics: Animals; Annexin A7; Aspirin; Calcium; Dinoprostone; Erythrocytes; Genotype; Hemoglobin A; Hemoglobi | 2009 |
Livedoid vasculopathy associated with sickle cell trait: significant improvement on aspirin treatment.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Biopsy; Follow-Up Studies; Humans; Livedo R | 2012 |
Vascular responsiveness to pressor agents during human pregnancy.
Topics: Aldosterone; Angiotensin II; Aspirin; Female; Hematocrit; Humans; Hypertension; Indomethacin; Pregna | 1979 |